Regional variation in survival following the diagnosis of cancer

Journal of Clinical Epidemiology

Volumn 49, Issue 8, 1996, Pages 843-847

  Farrow, Diana C ^a   Samet, Jonathan M ^b   Hunt, William C ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF NEW MEXICO HOSPITAL   (United States)

Author keywords

Epidemiology; Health services accessibility; Neoplasms; Survival rates

Indexed keywords

ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER SURVIVAL; COLON CANCER; GEOGRAPHIC PATHOLOGY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; STOMACH CANCER; SURVIVAL RATE; UTERUS CANCER;

EID: 0030220674     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-4356(96)00176-X     Document Type: Article

References (26)

1. 1. Farrow DC, Samet JM. Georgraphic variation in the treatment of localized breast cancer. N Engl J Med 1992; 326: 1087-1101.
2. 2. Nattinger AB, Gottlieb MS, Veum J, et al. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 1992; 326: 1102-1107.
3. 3. Chassin MR, Brook RH, Park RE, et al. Variations in the use of medical and surgical services by the Medicare population. N Engt J Med 1986; 314: 285-290.
4. 4. Chassin M, Kosecoff J, Park RE, et al. Does inappropriate use explain geographic variations in the use of health care services? A study of three procedures. JAMA 1987; 258: 2533-2537.
5. 5. Leape BL, Park RE, Solomon DH, et al. Does inappropriate use explain small-area variations in the use of health care service? JAMA 1990; 263: 669-672.
6. 6. Wennberg JE, Freeman JL, Shelton RM, et al. Hospital use and mortality among Medicare beneficiaries in Boston and New Haven. N Engl J Med 1989; 321: 1168-1173.
7. 7. Wennberg J, Gittelsohn A. Small area variations in health care delivery. Science 1973; 182: 1102-1108.
8. 8. Wennberg JE, Freeman JL, Culp WJ. Are hospital services rationed in New Haven or over-utilized in Boston? Lancet 1987; 1: 1185-1189.
9. 9. U.S. Department of Health and Human Services. Surveillance, Epidemiology, and End Results (SEER Program): Incidence and Mortality Data, 1973-77.
10. 10. Shambaugh EW, Weiss MA, Axtell LM, Eds. Summary Staging Guide: Cancer Surveillance, Epidemiology, and End Results (SEER) Program. Bethesda, Maryland: National Institutes of Health; 1977, HEW Publication No. (NIH) 77-1448.
11. 11. SAS Institute I. SAS User's Guide: Statistics, Version 6. Cary, North Carolina: SAS Institute, Inc.; 1990.
12. 12. SAS Institute I. SAS/STAT Software: The PHREG Procedure, Preliminary Documentation. Cary, North Carolina: SAS Institute, Inc.; 1991.
13. 13. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure from Data. New York: John Wiley; 1980.
14. 14. Hosmer DW Jr, Lemeshow S. Applied Logistic Regression. New York: John Wiley; 1989.
15. 15. Piantadosi S, Byar DP, Gail MH. Screening geographic areas for unusual survival experience of stage at diagnosis with application to breast and colon cancer. J Natl Cancer Inst 1985; 75: 269-275.
16. 16. Division of Cancer Prevention and Control and Division of Cancer Treatment, National Cancer Institute. 1987 Annual Cancer Statistics Review: Including Cancer Trends: 1950-1985. Bethesda, Maryland: U.S. Department of Health and Human Services, Public Health Service; 1988, NIH Publication No. 88-2789.
17. 17. Greenfield S, Aronow HU, Elashoff RM, Watanabe D. Flaws in mortality data. The hazards of ignoring comorbid disease. JAMA 1988; 260: 2253-2255.
18. 18. Smart C. The potential for progress in cancer management today. Bull Am Col Surg 1983; 68: 12-15.
19. 19. Mettlin CJ, Schoenfeld ER, Natarajan N, et al. Interhospital differences in cancer survival. J Chron Dis 1987; 40: 157-164.
20. 20. McClellan WM, Flanders WD, Gutman RA. Variable mortality rates among dialysis treatment centers. Ann Intern Med 1992; 117: 332-336.
21. 21. Pickering RM, Chadwell IR, Mountney L. Importance of district of residence and known primary site for bowel cancer survival: analysis of data from Wessex Cancer Registry. J Epidemiol Commun Health 1992; 46: 266-270.
22. 22. Baak JPA, Wisse-Brekelmans ECM, Kurver PHJ, Van Gorp LHM, Voorhorst FJ, Miettinen OS. Regional differences in breast cancer survival are correlated with differences in differentiation and rate of proliferation. Human Pathology 1992; 23: 989-992.
23. 23. Karjalainen S. Geographical variation in cancer patient survival in Finland: chance, confounding, or effect of treatment? J Epidemiol Commun Health 1990; 44: 210-214.
24. 24. Hakama M, Karjalainen S, Hakulinen T. Outcome-based equity in treatment of colon cancer patients in Finland. Int F Technology Assessment Health Care 1989; 5: 619-630.
25. 25. Auvinen A. Social class and colon cancer survival in Finland. Cancer 1992; 70: 402-409.
26. 26. McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. Br Med J 1991; 302: 1501-1505.